NAV
$163.90
AUM
$38.2B
Expense Ratio
-
Dividend Yield
1.13%
Beta
0.56
Currency
USD
| YTD | 1M | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|
| +5.78% | +7.01% | +11.94% | +21.87% | +9.36% | +6.71% |
| # | Symbol | Name | Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Co | 16.18% |
| 2 | JNJ | Johnson & Johnson | 10.03% |
| 3 | ABBV | AbbVie Inc | 7.11% |
| 4 | UNH | UnitedHealth Group Inc | 6.37% |
| 5 | MRK | Merck & Co Inc | 5.45% |
| 6 | TMO | Thermo Fisher Scientific Inc | 3.42% |
| 7 | AMGN | Amgen Inc | 3.35% |
| 8 | GILD | Gilead Sciences Inc | 3.08% |
| 9 | ISRG | Intuitive Surgical Inc | 2.79% |
| 10 | PFE | Pfizer Inc | 2.75% |
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Inception Date: 1998-12-16